Scancell Holdings Plc

Scancell Holdings Plc

Sector: Biological Products Except Diagnostic Substances Region: United Kingdom

: | London Stock Exchange: SCLP

Similar to: ALLENEX AB, NPS Pharmaceuticals, Inc., Bebra Biogas Holding AG

Scancell Holdings Plc is a biopharmaceutical company, which develops novel therapeutic vaccines for the treatment of cancer and infectious diseases. The company's clinical candidate drug cancer vaccine SCIB1 is a plasmid DNA, which encodes a human antibody molecule engineered to express a melanoma antigen called Tyrosinase-Related Protein 2 plus two helper T cell epitopes. Scancell Holdings founded by Lindy Gillian Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

News & Analysis

You may also be interested in: